NMS Labs
NMS Labs launches pain management lab test for Milnacipran, a new drug approved by the FDA for the treatment of Fibromyalgia pain
Published in Medical Letter on the CDC and FDA, April 18th, 2010
NMS Labs launches another unique test suitable for the evaluation of toxicity vs. efficacy, the potential for physicians to establish therapeutic drug monitoring (TDM) of individual patients, and the assessment of drug diversion of a new pain management drug therapy. NMS Labs is the only known commercial laboratory to develop and perform a clinical quantitative assay for Milnacipran (Savella®) using the highly specific and sensitive technique of liquid chromatography/tandem mass spectrometry (LC-MS/MS).
Eric Rieders, PhD, President and CEO expressed the importance of innovation at NMS Labs by saying, "We best serve the medical community by deploying our...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Infectious Diseases Society of America
Study finds surgical masks provided effective protection of health-care workers against H1N1 - NIH/National Institute of Allergy and Infectious Diseases
Rapid development of drug-resistant 2009 H1N1 influenza reported in 2 cases - Adenosine Therapy
Research results from Mayo Clinic update understanding of adenosine therapy - Alloimmunization
Study data from Emory University, Medical Department update understanding of alloimmunization - Arthritis
COLCRYS(R) (Colchicine, USP) Shows Superior Safety With Comparable - Breast Implants
Recent studies by J.C.S. Goes and co-authors add new data to breast implants findings - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
